Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.

MLA

Beyer-Westendorf, Jan, et al. “Effectiveness and Safety of Dabigatran Therapy in Daily-Care Patients with Atrial Fibrillation. Results from the Dresden NOAC Registry.” Thrombosis and Haemostasis, vol. 113, no. 6, June 2015, pp. 1247–57. EBSCOhost, https://doi.org/10.1160/TH14-11-0954.

APA

Beyer-Westendorf, J., Ebertz, F., Förster, K., Gelbricht, V., Michalski, F., Köhler, C., Werth, S., Endig, H., Pannach, S., Tittl, L., Sahin, K., Daschkow, K., & Weiss, N. (2015). Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry. Thrombosis and Haemostasis, 113(6), 1247–1257. https://doi.org/10.1160/TH14-11-0954

Chicago

Beyer-Westendorf, Jan, Franziska Ebertz, Kait Förster, Vera Gelbricht, Franziska Michalski, Christina Köhler, Sebastian Werth, et al. 2015. “Effectiveness and Safety of Dabigatran Therapy in Daily-Care Patients with Atrial Fibrillation. Results from the Dresden NOAC Registry.” Thrombosis and Haemostasis 113 (6): 1247–57. doi:10.1160/TH14-11-0954.